Carrillo-Arteaga HS, Valencia-Avendaño J, Oliveros-Ruiz L

Language: Spanish
References: 21
Page: 18-25
PDF size: 466.48 Kb.

ABSTRACT

Background: Ciclooxigenase inhibitors such as indometacin and ibuprofen, currently used for closure of the ductus arteriousus (DA) are associated with significant adverse effects on the newborn, so it is important to explore new alternatives of effective and safe treatment. One of these could be intravenous paracetamol.
Objective: Evaluate the efficacy and safety of intravenous paracetamol for the closure of DA in preterm newborns.
Material and Methods: We performed a prospective, experimental study, in preterm newborns with echocardiographic diagnosis of hemodynamically persistent ductus arteriousus (PDA), who were administered intravenous paracetamol 15mg/kg/day every six hours for three to seven days. In the follow up of these patients we looked for DA closure and side effects of paracetamol.
Results: We included nine preterm newborn with gestacional age and weight mean of 33.2 weeks and 1509 grams respectively. Five patient (55%) had Yeh index ≥ 3 and by echocardiography the mean internal diameter of the DA was 2.81 ± 1.05 mm., with a ratio of left atrium/ aortic root (LA/Ao): 1.5 ± 0.32. Closure of DA was detected in eight (89%) patients; closure average time was 3.4 ± 1.7 days. No adverse reactions were detected.
Conclusions: Intravenous paracetamol can be an effective and safe alternative treatment for closure of hemodinamically significant DA; however further studies are needed to validate these initial observations.

REFERENCES

1. Noori S, McCoy M, Friedlich P, Bright B, Gottipati V, Seri I, et al. Failure of Ductus Arteriosus Closure Is Associated With Increased Mortality in Preterm Infants. Pediatrics 2009;123(1):e138-144.

2. Evans N, Malcolm G, Osborn D, Kluckow M. Diagnosis of Patent Ductus Arteriosus in Preterm Infants. Neo Reviews 2004;5:e86-97.

3. Alva EC. Lo esencial de la cardiología. 1ra ed. México: McGraw-Hill Interamericana. 2006;73-81

4. Bökenkamp-Gramann, R., 2012, Doctoral thesis, Leiden University “The ductus arteriosus: a fetal vessel coming of age.” ISBN 9789461083333

5. Tapia-Rombo CA, Calvo-Rangel KM, Saucedo-Zavala VJ, Mora-Fol JR, Santiago-Romo JE. Evolución final de recién nacidos prematuros operados y no operados por persistencia del conducto arterioso. Gac Méd Méx 2008;144:111- 120.

6. Evans N, Malcolm G, Osborn D, Kluckow M. Diagnosis of Patent Ductus Arteriosus in Preterm Infants. Neo Reviews 2004;5:e86-97.

7. Clyman RI. Patent ductus arteriosus in preterm neonates. In: Avery’s diseases of the newborn. Eds: Taeush HW, Ballard RA. Philadelphia.7th ed. WB Saunders pp. 699-710.

8. Medrano LC, Guía TJM, Rueda NF, Moruno TA. Actualización en cardiología y cardiopatías congénitas. Rev Esp Cardiol 2009;62:39-52.

9. Skinner J. Diagnosis of patent ductus arteriousus. Sem Neonatol 2001;6:49-61.

10. Urquhart DS, Nicholl RM. How good is clinical examination at detecting a significant patent ductus arteriousus in the preterm neonate?. Arch Dis Child 2003;88:85-86.

11. Cherif A, Khrouf N, Jabnoun S, Mokrani C, Moez Ben A, Guellouze N, Kacem S. Randomized Pilot Study Comparing Oral Ibuprofen With Intravenous Ibuprofen in Very Low Birth Weight Infants With Patent Ductus Arteriosus. Pediatrics 2008;122:e1256-1261.

12. De Carolis MP, Romagnoli C, Polimeni V, Piersigilli F, Zecca E, Pappacci P et al. Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants. Eur J Pediatr 2000;159:364-368.

13. Petra M, Lemmers A, Toet MC, van Bel F. Impact of Patent Ductus Arteriosus and Subsequent Therapy with Indomethacin on Cerebral Oxygenation in Preterm Infants. Pediatrics 2008;121:142-147.

14. Zecca E, Romagnoli C, De Carolis M, Costa S, Marra R, De Luca D. Does Ibuprofen increase neonatal hyperbilirubinemia? Pediatrics 2009;124:480-484.

15. Quinn D, Cooper B, Clyman R. Factors associated with permanent closure of the Ductus Arteriosus: A Role for Prolonged Indomethacin Therapy. Pediatrics 2002;110; e10.

16. Hammerman C, Bin-Nun A, Markovitch E, Schimmel MS, Kaplan M, Fink D. Ductal closure with Paracetamol: A Surprising New Approach to Patent Ductus Arteriousus. Pediatrics 2011;128:e1618-1621.

17. Oncel MY, Yurttutan S, Uras N, Altug N, Ozdemir R, et.al “An alternative drug (paracetamol) in the management of patent ductus arteriosus in ibuprofen-resistant or contraindicated preterm infants”. Arch Dis Child Fetal Neonatal Ed. 2013;98(1):F94 doi:10.1136/archdischild- 2012-302044.

18. Bell EF, Acarregui MJ. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2000;(2):CD000503.

19. Golombek SG, Sola A, Baquero H, Borbonet D, Cabañas F, Fajardo C. Primer consenso clínico de SIBEN: enfoque diagnóstico y terapéutico del Ductus arterioso permeable en recién nacidos pretérmino. An Pediatr (Barc) 2008;69(5):454-81.

20. Oncel MY, Yurttutan S, Degirmecioglu H, Uras N, Altug N, Erdeve O, et al. Intravenous Paracetamol Treatment in the Management of Patent Ductus Arteriousus in Extremely Low Birth Weight Infants. Neonatology 2013;103:166-169.

21. Serafettin TK, Ceviz N, Demirelli Y, Olgun H, Caner I, Oguz SI, et al. Intravenous Paracetamol for Patent Ductus Arteriousus In Premature Infants- A Lower Dose Is Also Effective. Neonatology 2013;104:6-7.